Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 21
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

Long-term cardiovascular outcomes of COVID-19
Yan Xie, Evan Xu, Benjamin Bowe, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 583-590
Open Access | Times Cited: 1604
Long-term neurologic outcomes of COVID-19
Evan Xu, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2406-2415
Open Access | Times Cited: 378
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 305
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 216
Long COVID following Mild SARS-CoV-2 Infection: Characteristic T Cell Alterations and Response to Antihistamines
Paul Glynne, Natasha Tahmasebi, Vanya Gant, et al.
Journal of Investigative Medicine (2021) Vol. 70, Iss. 1, pp. 61-67
Open Access | Times Cited: 169
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
Markus Aldén, Francisko Olofsson Falla, Daowei Yang, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 3, pp. 1115-1126
Open Access | Times Cited: 149
COVID-19 and its long-term sequelae: what do we know in 2023?
Giuseppe Lippi, Fabián Sanchis‐Gomar, Brandon Michael Henry
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 127
A split prime editor with untethered reverse transcriptase and circular RNA template
Bin Liu, Xiaolong Dong, Haoyang Cheng, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 9, pp. 1388-1393
Closed Access | Times Cited: 116
Persistent post–COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium
John B. Finlay, David H. Brann, Ralph Abi Hachem, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 676
Open Access | Times Cited: 101
Long Covid: where we stand and challenges ahead
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 98
Long-term gastrointestinal outcomes of COVID-19
Evan Xu, Yan Xie, Ziyad Al‐Aly
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 92
Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19
Vaughn D. Craddock, Aatish Mahajan, Leslie Spikes, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 87
The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
Shaymaa Khazaal, Julien Harb, Mohamad Rima, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2903-2903
Open Access | Times Cited: 73
DNA Vaccines: Their Formulations, Engineering and Delivery
Michael Kozak, Jiafen Hu
Vaccines (2024) Vol. 12, Iss. 1, pp. 71-71
Open Access | Times Cited: 27
Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19
Hythem Sidky, Kristen Hansen, Andrew T. Girvin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 115-125
Open Access | Times Cited: 15
Long COVID: long-term effects?
Alessandro Di Toro, Antonio Bozzani, Guido Tavazzi, et al.
European Heart Journal Supplements (2021) Vol. 23, Iss. Supplement_E, pp. E1-E5
Open Access | Times Cited: 67
Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin
AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, et al.
(2021)
Open Access | Times Cited: 64
JAK inhibitors and COVID-19
Gabriel Levy, Paola Guglielmelli, Peter Langmuir, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e002838-e002838
Open Access | Times Cited: 50
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Marco Cosentino, Franca Marino
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10881-10881
Open Access | Times Cited: 41
Bat pluripotent stem cells reveal unusual entanglement between host and viruses
Marion Déjosez, Arturo Marín, Graham M. Hughes, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 957-974.e28
Open Access | Times Cited: 38
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis
Simone Turner, Caitlin A. Naidoo, Thomas J. Usher, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 02, pp. 288-294
Closed Access | Times Cited: 33
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Karina Acevedo‐Whitehouse, Roxana Bruno
Medical Hypotheses (2023) Vol. 171, pp. 111015-111015
Open Access | Times Cited: 27
An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109934-109934
Open Access | Times Cited: 27
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
Hélène Banoun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10514-10514
Open Access | Times Cited: 24
The mRNA-LNP vaccines – the good, the bad and the ugly?
Botond Z. Igyártó, Zhen Qin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top